Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Twist Bioscience Corporation

Market Cap 5.29B 4.56B 4.2B 3.94B 7.4B 500B 7.48B 49.61B 19.33B 245B 19.85B 19.43B 849B P/E Ratio 2026 *
-42x
P/E Ratio 2027 * -58.1x
Enterprise Value 5.29B 4.56B 4.2B 3.94B 7.4B 500B 7.48B 49.61B 19.33B 245B 19.85B 19.43B 849B EV / Sales 2026 *
11.8x
EV / Sales 2027 * 10.2x
Free-Float
98.5%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Twist Bioscience Corporation

1 day+5.15%
1 week+21.25%
Current month+27.04%
1 month+72.77%
3 months+88.74%
6 months+172.89%
Current year+167.81%
1 week 68.45
Extreme 68.45
86.94
1 month 48.03
Extreme 48.03
86.94
Current year 31.43
Extreme 31.43
86.94
1 year 23.3
Extreme 23.3
86.94
3 years 14.42
Extreme 14.42
86.94
5 years 11.46
Extreme 11.46
139.99
10 years 11.46
Extreme 11.46
214.07
Manager TitleAgeSince
Chief Executive Officer 52 01/01/2013
Director of Finance/CFO 49 05/01/2024
President 54 25/10/2022
Director TitleAgeSince
Chairman 52 25/10/2022
Director/Board Member 65 01/10/2013
Director/Board Member 67 01/06/2014
Date Insider Type Main position Quantity % Market Cap.
08/06Sell

Head of Human Resources

-884 0.0014%
08/06Sell

Controller/Auditor

-1,859 0.0030%
08/06Sell

Chief Executive Officer

-2,265 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+5.15%+21.25%+142.44%+363.95% 5.29B
-0.04%-0.24%+17.61%-21.50% 62.54B
-0.84%-6.24%+56.75%+194.42% 55.22B
+0.08%+33.30%+33.30%+33.30% 40.9B
+0.51%+3.73%-55.37%-62.46% 35.99B
-1.53%-1.75%+49.28%-34.24% 28.88B
+6.27%+16.07%+113.08%-56.96% 21.98B
-2.19%-3.37%+40.06%+57.76% 19.93B
-2.03%+0.67%-2.92%+110.25% 16.95B
+0.51%-0.69%+53.96%+98.17% 15.87B
Average +0.59%+4.00%+44.82%+68.27% 30.36B
Weighted average by Cap. +0.08%+1.60%+32.52%+42.06%

Financials

2026 *2027 *
Net sales 446M 385M 354M 333M 625M 42.21B 631M 4.19B 1.63B 20.67B 1.68B 1.64B 71.63B 518M 447M 411M 386M 725M 49B 733M 4.86B 1.89B 23.99B 1.94B 1.9B 83.15B
Net income -129M -111M -102M -96.08M -180M -12.19B -182M -1.21B -471M -5.97B -484M -474M -20.69B -87.65M -75.53M -69.56M -65.31M -123M -8.29B -124M -822M -320M -4.06B -329M -322M -14.06B
Net Debt - -
Logo Twist Bioscience Corporation
Twist Bioscience Corporation provides customizable solutions across the biological continuum that enable scientific discovery and development across therapeutics, diagnostics, and other high-growth markets. The Company's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The Company has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.
Employees
979
Date Price Change Volume
16/06/26 84.95 $ +5.15% 2,482,190
15/06/26 80.79 $ +6.07% 2,642,802
12/06/26 76.17 $ +2.86% 2,612,144
11/06/26 74.05 $ +9.27% 2,743,154
10/06/26 67.77 $ -3.27% 1,145,554
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
84.95USD
Average target price
71.10USD
Spread / Average Target
-16.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TWST Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!